Is common balding in women managed differently than in men?

Women whose balding is a manifestation of hyperandrogenism (excessive production of circulating androgens) may benefit from therapy directed at the cause of hyperandrogenism. Polycystic ovarian disease, late-on-set congenital adrenal hyperplasia, Cushing’s syndrome, and adrenal and ovarian neoplasms are potential causes of hyperandrogenism. In the absence of elevated circulating androgens, nonspecific therapy directed at suppressing ovarian androgen production or blocking the peripheral effect of androgens is sometimes tried. Oral contraceptive agents (to suppress ovarian androgen production) and spironolactone are most often utilized for this purpose. Topical minoxidil solution is also useful, but oral finasteride is seldom used in women.